ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Relay Therapeutics Inc

Relay Therapeutics Inc (RLAY)

13,93
-0,61
( -4,20% )
Mis à jour : 16:04:54

Relay Therapeutics Inc (RLAY) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
13,93
( -4,20% )
Prix Achat
13,89
Prix Vente
13,96
Volume échangé
405 253
13,845 Fourchette du Jour 14,54
2,98 Plage de 52 semaines 17,47
Cap du marché
Clôture Veille
14,54
Ouverture
14,54
Dernière Transaction
3
@
13.9329
Dernière heure de transaction
16:05:04
Volume financier
US$ 5 716 303
VWAP
14,1055
Volume moyen (3 m)
US$ 3 543 144
Actions en circulation
217 940 332
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-8,88
Bénéfice par action (BPA)
-1,57
Chiffre d'affairess (LTM)
10,68M
Bénéfice net (LTM)
-272,71M

À propos de Relay Therapeutics Inc

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company’s lead product candidates include RLY-2608, a p... Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company’s lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGal chaperone for Fabry diseases. It also develops RLY-8161, an oncogene driver that belongs to the RAS family of signaling proteins. In addition, the company develops lirafugratinib (RLY-4008), a receptor tyrosine kinase for the treatment of cancer. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; Elevar Therapeutics, Inc. for the development and commercialization of RLY-4008; and Pfizer Inc. for the development of RLY-2608 in combination with fulvestrant and atirmociclib. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Cambridge, United States
Fondé
2026
Relay Therapeutics Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker RLAY. Le dernier cours de clôture d'Relay Therapeutics était de US$14,54. Au cours de la dernière année, les actions de Relay Therapeutics ont été négociées dans une fourchette de prix de US$ 2,98 à US$ 17,47.

Relay Therapeutics compte actuellement 217 940 332 actions en circulation. La capitalisation boursière d'Relay Therapeutics est de US$3,04 milliard. Relay Therapeutics a un ratio cours/bénéfice (ratio PE) de -8.88.

RLAY Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.161.1619462599913.7717.4713.3534436815.05724041CS
41.3210.467882632812.6117.4711.62498843913.56284396CS
122.9326.63636363641117.479.265368337713.32538998CS
265.973.47447073478.0317.477.09298124611.37612987CS
5210.7331.2693498453.2317.472.9824454418.78606692CS
1562.4621.447253705311.4717.471.77518898337.48258698CS
260-18.37-56.873065015532.338.6051.775153471911.17022767CS

RLAY - Frequently Asked Questions (FAQ)

What is the current Relay Therapeutics Inc share price?
The current share price of Relay Therapeutics Inc is US$ 13,93
How many Relay Therapeutics Inc shares are in issue?
Relay Therapeutics Inc has 217 940 332 shares in issue
What is the market cap of Relay Therapeutics Inc?
The market capitalisation of Relay Therapeutics Inc is USD 3,04B
What is the 1 year trading range for Relay Therapeutics Inc share price?
Relay Therapeutics Inc has traded in the range of US$ 2,98 to US$ 17,47 during the past year
What is the PE ratio of Relay Therapeutics Inc?
The price to earnings ratio of Relay Therapeutics Inc is -8,88
What is the cash to sales ratio of Relay Therapeutics Inc?
The cash to sales ratio of Relay Therapeutics Inc is 283,76
What is the registered address of Relay Therapeutics Inc?
The registered address for Relay Therapeutics Inc is 60 Hampshire Street, Cambridge, Massachusetts, 02139
What is the Relay Therapeutics Inc website address?
The website address for Relay Therapeutics Inc is www.relaytx.com
Which industry sector does Relay Therapeutics Inc operate in?
Relay Therapeutics Inc operates in the Biotechnology & Life Sciences sector

RLAY Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion